MIRacle™ rno-miR-194-5p miRNA Agomir/Antagomir

Description

MIRacle™ rno-miR-194-5p miRNA Agomir/Antagomir is a chemically modified synthetic oligonucleotide developed to precisely modulate the activity of endogenous microRNAs. The Agomir functions as a miRNA mimic, effectively enhancing the expression and biological activity of rno-miR-194-5p. Whereas the Antagomir serves as a sequence-specific antagonist, inhibiting rno-miR-194-5p function. Both formulations are optimized for high stability and efficacy in in vitro and in vivo settings. AcceGen provides the MIRacle™ series in multiple specifications (2 OD, 4 OD, 50 OD) with HPLC purification to accommodate a diverse range of experimental requirements. These reagents are ideal for investigating the role of target miRNA in key biological processes including neuronal cell death, ischemic tolerance, and the regulation of neuroprotective pathways via SUMO2 modulation. In advanced research workflows, MIRacle™ technology–based miRNA modulating agents enable comprehensive evaluation of miR-194-5p cellular function, disease relevance, expression dynamics, and target gene identification, while supporting agomir- and antagomir-based therapeutic strategies through efficient MIRacle miRNA delivery, thereby expanding rno-miR-194-5p applications.